Monday, 13 July 2026
Subscribe free
The independent voice of UK resident doctors215 conferences · 6 journals 55 societies · 285+ resources

MedicMess

The first UK medical conference website

Conferences · Journals · Societies · Research, for UK resident doctors

HomeConferencesDiagnostics and ScreeningScreening360 2026: Advancing Diagnostic Screening Through Imaging, Pathology & AI
Diagnostics and Screening · Annual Conference

Screening360 2026: Advancing Diagnostic Screening Through Imaging, Pathology & AI

Organised by the Convenzis Group Limited
Dates23–23 Sept 2026
Venueetc.venues Prospero House, 241 Borough High Street, London
CityLondon, United Kingdom
CPD Points8 CPD
Screening360 2026: Advancing Diagnostic Screening Through Imaging, Pathology & AI is a Convenzis healthcare conference for NHS and public-sector professionals focused on diagnostics and screening.
Reviewed byDr Robert BaxterDr Robert Baxter· Junior Clinical Fellow, Acute Medical Unit· Updated 13 Jul 2026
MedicMess Conference Intelligence
Networking
Convenzis describes structured networking, supplier stands, panel discussion and Q&A as part of the delegate pass.
Research Value
No public abstract or research-submission pathway was identified on the rendered event page.
Trainee Relevance
A free NHS ticket is visible on the Convenzis page, but attendance is by pre-registration/approval and aimed mainly at senior NHS managers.
Audience
NHS and public-sector leaders, clinicians, service managers and transformation teams interested in diagnostics and screening.
Programme Highlights
Key Themes
AI-enabled screening workflowsImaging and pathology integrationCancer diagnostic pathwaysCommunity screening capacityClinical governance and safety
Theme
AI-enabled screening workflows
Theme
Imaging and pathology integration
Theme
Cancer diagnostic pathways
Theme
Community screening capacity
Theme
Clinical governance and safety

MedicMess Tips

  • Book via the official Convenzis page; NHS free-ticket eligibility is subject to pre-registration and approval where shown.
  • The page states that unregistered guests/private-sector representatives are not admitted unless approved.
  • Use the venue link on the Convenzis page for current access details.
Cost & Registration
CategoryPrice
Standard registration£500
Trainee / IMTFree
Key Deadlines
23 Sept 2026 · 72 days
Conference begins
Conference Snapshot
SpecialtyDiagnostics and Screening
Organising societyConvenzis Group Limited
CPD accreditation8 CPD points
Conference formatIn-person only
Locationetc.venues Prospero House, 241 Borough High Street, London, London
The Complete Guide to the Screening360 2026: Advancing Diagnostic Screening Through Imaging, Pathology & AI

Screening360 2026: Advancing Diagnostic Screening Through Imaging, Pathology & AI is a Convenzis-hosted healthcare conference taking place at etc.venues Prospero House, 241 Borough High Street, London on 23 Sep 2026. The rendered Convenzis page presents it as a multi-session forum for NHS and public-sector leaders, clinicians, operational teams and suppliers working on diagnostics and screening. The programme material visible on the page is organised around themes including AI-enabled screening workflows, Imaging and pathology integration, Cancer diagnostic pathways, Community screening capacity, Clinical governance and safety. Convenzis states that its events provide access to a speaker programme, interactive Q&A, fireside interviews, panel discussions, morning refreshments, hot lunch and networking. Where stated, the event is CPD accredited for 8 CPD points. Ticketing was visible in read-only mode on the event page: most Convenzis NHS events show a free NHS senior-manager ticket subject to pre-registration/approval and a private-sector ticket at GBP 500 excluding VAT; where that pricing was not visible, the pricing note is retained on the source page record. No public abstract submission route was identified on the rendered Convenzis page for this listing, so presentation fields have been left blank rather than invented. Trainees should treat these as service-transformation, leadership, diagnostics or digital-health meetings rather than traditional abstract-led society congresses.